Australia - inglés - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - gabapentin, quantity: 100 mg - capsule, hard - excipient ingredients: maize starch; purified talc; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,gabapentin is indicated for the treatment of neuropathic pain.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: purified talc; maize starch; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,gabapentin is indicated for the treatment of neuropathic pain.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,gabapentin is indicated for the treatment of neuropathic pain.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

micro labs pty ltd - gabapentin, quantity: 100 mg - capsule, hard - excipient ingredients: purified talc; maize starch; titanium dioxide; purified water; gelatin; sodium lauryl sulfate - gabapentin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,gabapentin is indicated for the treatment of neuropathic pain.

Canadá - inglés - Health Canada

amicus therapeutics canada inc. - migalastat (migalastat hydrochloride) - capsule - 123mg - migalastat (migalastat hydrochloride) 123mg - other miscellaneous therapeutic agents

Estados Unidos - inglés - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - ondansetron hydrochloride (unii: nmh84ozk2b) (ondansetron - unii:4af302esos) - ondansetron 4 mg - - prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy, including cisplatin ≥ 50 mg/m 2 . - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy. - prevention of nausea and vomiting associated with radiotherapy in patients receiving either total body irradiation, single high-dose fraction to the abdomen, or daily fractions to the abdomen. - prevention of postoperative nausea and/or vomiting. as with other antiemetics, routine prophylaxis is not recommended for patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. in patients where nausea and/or vomiting must be avoided postoperatively, ondansetron tablets are recommended even where the incidence of postoperative nausea and/or vomiting is low. the concomitant use of apomorphine with ondansetron is contraindicated based on reports of profound hypotension and loss of consciousness when apomorphine w

Estados Unidos - inglés - NLM (National Library of Medicine)

amicus therapeutics us, llc - migalastat hydrochloride (unii: cly7m0xd20) (migalastat - unii:c4xny919fw) - galafold is indicated for the treatment of adults with a confirmed diagnosis of fabry disease and an amenable galactosidase alpha gene (gla ) variant based on in vitro assay data [see dosage and administration (2.1) and clinical pharmacology (12.1)] . this indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (kic gl-3) substrate [see clinical studies (14)] . continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. none. risk summary there were three pregnant women with fabry disease exposed to galafold in clinical trials. as such, the available data are not sufficient to assess drug associated risks of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, no adverse developmental effects were observed (see data) . the background risk for major birth defects and miscarriage for the indicated population is unk

Estados Unidos - inglés - NLM (National Library of Medicine)

heb - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - pain reliever/fever reducer - temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis - headache - toothache - backache - menstrual cramps - the common cold - muscular aches - minor pain of arthritis - temporarily reduces fever

Estados Unidos - inglés - NLM (National Library of Medicine)

marc glassman, inc. - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm) - pain reliever/fever reducer - temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis - headache - toothache - backache - menstrual cramps - the common cold - muscular aches - minor pain of arthritis - temporarily reduces fever

Estados Unidos - inglés - NLM (National Library of Medicine)

rite aid - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), benzocaine (unii: u3rsy48jw5) (benzocaine - unii:u3rsy48jw5) - purpose oral pain reliever oral pain reliever astringent use - for the temporary relief of oral pain due to minor irritation or injury of the mouth and gums